Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles - Dove Medical Press

Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles Dove Medical Press Abstract: Currently, therapy for thyroid cancer mainly involves surgery and radioiodine therapy. However, chemotherapy can be used in advanced and aggressive thyroid cancer that cannot be treated by other options. Nevertheless, a major obstacle to the ...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vjp4pu
via IFTTT